⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
VTGN News
Vistagen Therapeutics, Inc. Common Stock
Pomerantz LLP Advises Shareholders of Class Action Involving Vistagen Therapeutics, Inc. – VTGN
accessnewswire.com
VTGN
VTGN CLASS ACTION ALERT: Robbins LLP Urges Vistagen Therapeutics, Inc. Stockholders to Reach Out for Information About the Securities Class Action Lawsuit
prnewswire.com
VTGN
Bragar Eagel & Squire, P.C. Urges Vistagen Therapeutics, Inc. Stockholders to Contact the Firm Regarding The Upcoming Lead Plaintiff Deadline for the Filed Class Action Lawsuit
globenewswire.com
VTGN
The Gross Law Firm Reminds Vistagen Therapeutics, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 16, 2026 – VTGN
globenewswire.com
VTGN
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Vistagen Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VTGN
globenewswire.com
VTGN
March 16, 2026 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against VTGN
prnewswire.com
VTGN
VTGN INVESTOR ALERT -- LEVI & KORSINSKY, LLP ANNOUNCES CLASS ACTION OVER ALLEGED MISLEADING STATEMENTS ABOUT CLINICAL TRIAL PROGRESS
prnewswire.com
VTGN
UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Vistagen Therapeutics
globenewswire.com
VTGN
Lead Plaintiff Deadline of March 16, 2026 in the Vistagen Therapeutics, Inc. (VTGN) Securities Class Action Announced by Holzer & Holzer, LLC
globenewswire.com
VTGN
VTGN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Vistagen Therapeutics, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
VTGN